Get the Stockscreener App
5.26
2.41%
-0.13
Clover Health Investments Corp stock is traded at $5.26, with a volume of 5.88M.
It is down -2.41% in the last 24 hours and up +41.02% over the past month.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
See More
Previous Close:
$5.39
Open:
$5.4
24h Volume:
5.88M
Relative Volume:
0.78
Market Cap:
$2.77B
Revenue:
$2.21B
Net Income/Loss:
$-56.94M
P/E Ratio:
-46.80
EPS:
-0.1124
Net Cash Flow:
$54.54M
1W Performance:
+0.96%
1M Performance:
+41.02%
6M Performance:
+118.26%
1Y Performance:
+103.09%
1-Day Range:
$5.20
$5.51
1-Week Range:
$5.12
$5.59
52-Week Range:
$1.58
$5.59
Clover Health Investments Corp Stock (CLOV) Company Profile
Name
Clover Health Investments Corp
Sector
Industry
Phone
(201) 432-2133
Address
30 MONTGOMERY STREET, JERSEY CITY
Compare CLOV vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
5.26 | 2.76B | 2.21B | -56.94M | 54.54M | -0.1124 |
UNH
Unitedhealth Group Inc
|
425.36 | 377.45B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
104.72 | 131.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
417.89 | 83.98B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
287.77 | 72.93B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
396.75 | 47.69B | 137.20B | 1.15B | 1.27B | 9.3439 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Initiated | Craig Hallum | Buy |
| Oct-07-24 | Initiated | UBS | Neutral |
| Feb-02-22 | Initiated | Canaccord Genuity | Buy |
| Feb-02-22 | Upgrade | Cowen | Underperform → Market Perform |
| Jan-19-22 | Initiated | SVB Leerink | Mkt Perform |
| Jan-10-22 | Resumed | Citigroup | Neutral |
| Jan-07-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Sep-10-21 | Initiated | Cowen | Underperform |
| Sep-02-21 | Resumed | Citigroup | Neutral |
| Jul-12-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| May-17-21 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Feb-02-21 | Initiated | Citigroup | Buy |
| Feb-01-21 | Initiated | JP Morgan | Neutral |
View All
Clover Health Investments Corp Stock (CLOV) Latest News
Clover Health CEO Andrew Toy sells $1.67 million in stock - Investing.com
Form 4 Clover Health Investments Corp For: 1 July By Investing.com - Investing.com Canada
Clover Health CEO Andrew Toy sells $1.67 million in stock By Investing.com - Investing.com Canada
Clover Health (CLOV) CEO’s 313,476-share sale tied to RSU tax withholding - Stock Titan
[144] CLOVER HEALTH INVESTMENTS, CORP. /DE SEC Filing - Stock Titan
ETFs Investing in Clover Health Investments Corp. Class A Stocks - TradingView
A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction. - The Motley Fool
A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction. - The Motley Fool
Clover Health Investments Corp. Class A Actuals & Estimates (NASDAQ:CLOV) - TradingView
Clover Health Investments Corp. Class A Actuals & Estimates (BX:CLOV) - TradingView
Enterprise value to revenue forward of Clover Health Investments, Corp. – NASDAQ:CLOV - TradingView
Clover Health Investments Corp. Class A Actuals & Estimates (HAM:7QD) - TradingView
Price to sales forward of Clover Health Investments, Corp. – NASDAQ:CLOV - TradingView
Price to earnings forward of Clover Health Investments, Corp. – NASDAQ:CLOV - TradingView
7QD Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBIT forward of Clover Health Investments, Corp. – NASDAQ:CLOV - TradingView
CLOV Forecast — Price Target — Prediction for 2027 - TradingView
Clover Health stock hits 52-week high at 5.18 USD By Investing.com - Investing.com Australia
Clover Health stock hits 52-week high at 5.18 USD - Investing.com
Clover Health (CLOV): 3 Reasons We Love This Stock - Barchart.com
Jim Cramer Says Clover Health (CLOV) Was a Good Speculative Pick But Still Prefers UnitedHealth and CVS - Yahoo Finance
Why is Clover Health Investments stock surging today? By Investing.com - Investing.com Nigeria
16 Stocks on Jim Cramer’s Radar Like Oracle and Goldman Sachs - Insider Monkey
Clover reports CMS recalculation boosts two Medicare Advantage contracts to 4.5 Stars for 2027 - TradingView
Clover Health (CLOV) Medicare Advantage plans earn 4.5-Star CMS ratings for 2027 - Stock Titan
Clover Health Investments Stockanalyst views and Thursday technicals - AD HOC NEWS
symbol__ Stock Quote Price and Forecast - CNN
Insider Sell: Jamie Reynoso Sells Shares of Clover Health Investments Corp (CLOV) - GuruFocus
Clover Health CEO Jamie Reynoso sells $11,280 in class A stock - Investing.com Nigeria
Clover Health CEO Jamie Reynoso sells $11,280 in class A stock By Investing.com - Investing.com Australia
Clover Health (CLOV) executive sells 2,360 shares in 10b5-1 plan - Stock Titan
Clover Health Investments Corp (CLOV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Clover Health Investments Corp (CLOV) Institutional Confidence - TradingKey
Clover Health Investments Corp (CLOV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Clover Health Investments Corp (CLOV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Clover Health Investments Corp - TradingKey
Clover Health Investments Corp (CLOV) Valuation: PE, PB & Fair Value Analysis - TradingKey
Clover Health Investments Corp (CLOV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
2,360 RSUs listed for sale by CLOV (NASDAQ: CLOV); insider 10b5-1 sales noted - Stock Titan
Clover Health eliminates CEO role at home care business - The Business Journals
Clover Health VP of finance Oldakowski sells $58,815 in stock By Investing.com - Investing.com Nigeria
Clover Health VP of finance Oldakowski sells $58,815 in stock - Investing.com UK
Clover Health (CLOV) finance VP sells 12,102 shares in tax-related RSU transaction - Stock Titan
According to a document submitted to the SEC, Brady Priest, CEO of Clover Care Services, a subsidiary of Clover Health Investments, Corp., will step down on July 3, 2026. - Bitget
Brady Priest to Step Down as CEO of Clover Care Services at Clover Health Investments - TradingView
Clover Health (CLOV) CEO of home-care unit to depart as duties shift - Stock Titan
Clover Health chief legal officer Karen Soares sells $21,579 in stock - Investing.com Nigeria
Clover Health CEO Jamie Reynoso sells $29,273 in company stock By Investing.com - Investing.com India
Clover Health CEO Jamie Reynoso sells $29,273 in company stock - Investing.com
Clover Health (CLOV) legal chief sells 4,681 shares to cover taxes - Stock Titan
Clover Health (CLOV) executive logs small tax-related sell-to-cover stock sale - Stock Titan
Clover Health Investments Corp Stock (CLOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.87%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):